The National Academies of Sciences, Engineering, and Medicine’s Health and Medicine Division has convened a panel of experts to explain the science behind these drugs, discuss their expanding usage, and explore their larger societal implications in a free, public webinar. This informal conversation will be valuable to patients and their families, health care professionals, students, journalists, and anyone who would simply like to learn more about the topic.

The following panelists will also take questions from the audience:

Jamy Ard, MD, vice dean of clinical research at Wake Forest University School of Medicine; professor, Department of Epidemiology and Prevention; co-director, Advocate Health Wake Forest Baptist Weight Management Center

Ania M. Jastreboff, M.D., Ph.D., associate professor in medicine and pediatrics at Yale School of Medicine; director, Yale Obesity Research Center; codirector, Yale Center for Weight Management

Patty Nece, J.D., immediate past chair of the National Board of Directors of the Obesity Action Coalition (OAC); chair, OAC Weight Bias Committee

Donna Ryan, M.D., professor emerita at Pennington Biomedical in Baton Rouge, LA

Relevant Resources:

Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders: A Workshop
Medications and Obesity: Exploring the Landscape and Advancing Comprehensive Care: A Workshop